Orthocell Orthocell is a company that develops devices for regenerating mobility of tendon, cartilage, and soft tissue. | ![]() Celling Biosciences Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies. | ![]() Cardiva Medical Cardiva Medical designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional endovascular procedures. | ReCor Medical ReCor Medical is a medical device company that designs and manufactures the Paradise System, an ultrasound ablation system for renal denervation (RDN). | ||
Founding Date | Founding Date 2006 | Founding Date 2013 | Founding Date 2009 | Founding Date 2002 | Founding Date 2009 |
Type | Type Public | Type Private | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Murdoch, AU HQ | Locations Austin, US HQ Curitiba, BR Dubai, AE | Locations Natick, US HQ | Locations Santa Clara, US HQ | Locations Palo Alto, US HQ Sandwich, GB |
Employees | Employees N/A | Employees 47 | Employees 266 | Employees 2411% increase | Employees 3111% increase |
Valuation ($) | Valuation ($) 65.5 m | Valuation ($) N/A | Valuation ($) 49.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $7.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $15.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $2.2m (FY, 2025) | Cost of goods N/A | Cost of goods $5.7m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $5.7m (FY, 2025) | Gross profit N/A | Gross profit $9.6m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($8.6m) (FY, 2025) | Net income N/A | Net income ($28.8m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 90.5m | Total funding raised $ 112.7m | Total funding raised $ 15m |

Celling Biosciences is a company developing point-of-care systems, surgical techniques, and technology platforms that create the optimal environment for regenerative cell therapies.
View company
Allurion Technologies is a company that provides a weight loss platform.
View company
Cardiva Medical designs and develops vascular access management products that facilitate rapid hemostasis following diagnostic and interventional endovascular procedures.
View companyReCor Medical is a medical device company that designs and manufactures the Paradise System, an ultrasound ablation system for renal denervation (RDN).
View company